Puduvalli V K
Department of Neuro-Oncology, University of Texas M.D. Anderson Cancer Center, Box 431, 1515 Holcombe Boulevard, Houston, TX 77030, USA.
Curr Oncol Rep. 2001 Nov;3(6):467-75. doi: 10.1007/s11912-001-0067-7.
Metastatic lesions constitute the most frequently occurring malignancy in the brain, and their detection portends a grim prognosis. Efforts to treat these lesions have failed partly because the biologic processes that govern their development are poorly understood. In recent years, it has become evident that metastases occur as a result of a multistep process involving a rigorous natural selection of cells in the primary tumor that bear molecular and biologic characteristics permitting brain metastasis. In addition, recent studies have uncovered the importance of the brain microenvironment and its contribution to the metastatic process. The development of targeted therapies against brain metastases demands a better understanding of these molecular processes and the factors that influence them. This review examines the interplay between tumor cells and host brain tissue in the context of our current understanding of the role of various molecules involved in the metastatic process.
转移性病变是大脑中最常见的恶性肿瘤,其发现预示着预后不良。治疗这些病变的努力部分失败了,因为对其发展所涉及的生物学过程了解甚少。近年来,越来越明显的是,转移是一个多步骤过程的结果,该过程涉及对原发性肿瘤中具有允许脑转移的分子和生物学特征的细胞进行严格的自然选择。此外,最近的研究揭示了脑微环境的重要性及其对转移过程的贡献。开发针对脑转移的靶向治疗需要更好地理解这些分子过程以及影响它们的因素。本综述在我们目前对转移过程中涉及的各种分子作用的理解背景下,研究肿瘤细胞与宿主脑组织之间的相互作用。